Protocol Ledger

Clinical Biostatistics & Trial-Operations Monographs

ClinicalTrials.gov Completion, Therapeutic Timelines & Pipeline Research

Peer-auditable empirical studies built strictly from 54,890 interventional Phase II and Phase III ClinicalTrials.gov v2 studies (2018 to 2026), 22,436 canonicalized clinical sites, and 1,184 FDA Drugs@FDA original NDA and BLA approvals in publication 47c4426df7e9d67d5bfe.

Studies Indexed: 54,890 Completed Studies: 15,690 (6,796 stopped) Physical Sites: 22,436

Ten-Indication Phase II and Phase III Empirical Baseline (2018 to 2026)

Every Protocol Ledger study reconciles raw ClinicalTrials.gov v2 facility tuples, M&A subsidiary lineages, and date-horizon anomalies before computing completion and duration benchmarks for the Sponsor & Site Directory.

Reconciled Phase II and Phase III Study Volume, Completion, Enrollment, and Duration by Therapeutic Area
Code Therapeutic Area Protocols Completed Stopped Stop % Median N Median Days
ONC Oncology and Hematology 22,601 3,040 2,734 12.10% 43.0 1,269
OTH Rare Genetic, Women's Health, and Other 10,777 3,957 1,190 11.04% 60.0 572
INF Infectious Disease and Vaccines 5,536 2,510 933 16.85% 152.0 456
NEU Neurology, Psychiatry, and Pain 4,809 1,763 628 13.06% 84.0 714
IMM Immunology, Rheumatology, and Dermatology 3,376 1,249 466 13.80% 119.0 690
END Endocrinology, Obesity, and Metabolic 2,382 1,032 219 9.19% 113.0 616
CVM Cardiovascular and Thrombosis 2,184 799 245 11.22% 102.5 695
RSP Respiratory and Pulmonary 1,201 506 146 12.16% 91.0 651
GAS Gastroenterology, Hepatology, and Renal 1,088 396 140 12.87% 76.0 663
OPH Ophthalmology and Sensory 936 438 95 10.15% 106.0 427

Related Engineering Notes

Protocol Ledger applies deterministic entity reconciliation across ClinicalTrials.gov v2 and FDA Drugs@FDA archives. For technical background on how Meru AI resolves hospital campuses and biopharma sponsor lineages across federal sources, see Cross-Agency Entity Resolution, Citation-Grade Public Data Architecture, and the broader Meru AI Public Data Platforms overview.